StockData
COSCIENS Biopharma Inc. logo

COSCIENS Biopharma Inc. (CSCIF) stock

CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)

Close on Oct 19, 2026Market cap $24.10MP/E –Yield –

COSCIENS Biopharma total assets

Total assets on the balance sheet at the end of each period.

COSCIENS Biopharma's total assets was $18.84M at Mar 31, 2026. For fiscal 2025 it was $21.43M, down 38.9% from the year before. The highest annual figure on record is $80.10M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$21.43M-38.9%
FY2024Dec 31, 2024$35.07M+47.7%
FY2023Dec 31, 2023$23.75M-14.7%
FY2022Dec 31, 2022$27.84M-65.2%
FY2021Dec 31, 2021$80.10M+116.5%
FY2020Dec 31, 2020$37.01M+85.2%
FY2019Dec 31, 2019$19.98M-20.1%
FY2018Dec 31, 2018$25.01M+12.7%
FY2017Dec 31, 2017$22.20M-29.9%
FY2016Dec 31, 2016$31.66M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$18.84M-39.5%
Q4 FY2025Dec 31, 2025$21.43M-38.9%
Q3 FY2025Sep 30, 2025$23.86M-45.5%
Q2 FY2025Jun 30, 2025$27.56M-44.9%
Q1 FY2025Mar 31, 2025$31.14M-2.0%
Q4 FY2024Dec 31, 2024$35.07M+47.7%
Q3 FY2024Sep 30, 2024$43.77M+3.0%
Q2 FY2024Jun 30, 2024$50.05M+7.7%
Q1 FY2024Mar 31, 2024$31.79M-38.0%
Q4 FY2023Dec 31, 2023$23.75M-14.7%
Q3 FY2023Sep 30, 2023$42.49M-36.2%
Q2 FY2023Jun 30, 2023$46.48M-35.3%
Q1 FY2023Mar 31, 2023$51.28M-32.8%
Q4 FY2022Dec 31, 2022$27.84M-65.2%
Q3 FY2022Sep 30, 2022$66.61M-18.8%
Q2 FY2022Jun 30, 2022$71.83M-14.9%
Q1 FY2022Mar 31, 2022$76.34M-12.3%
Q4 FY2021Dec 31, 2021$80.10M+116.5%
Q3 FY2021Sep 30, 2021$82.04M+154.2%
Q2 FY2021Jun 30, 2021$84.35M+377.4%
Q1 FY2021Mar 31, 2021$87.01M+343.0%
Q4 FY2020Dec 31, 2020$37.01M+85.2%
Q3 FY2020Sep 30, 2020$32.27M+50.1%
Q2 FY2020Jun 30, 2020$17.67M-14.9%
Q1 FY2020Mar 31, 2020$19.64M-21.5%
Q4 FY2019Dec 31, 2019$19.98M-10.0%
Q3 FY2019Sep 30, 2019$21.50M-32.1%
Q2 FY2019Jun 30, 2019$20.75M–
Q4 FY2018Dec 31, 2018$25.01M–
Q4 FY2017Dec 31, 2017$22.20M–
Q4 FY2016Dec 31, 2016$31.66M–

More COSCIENS Biopharma figures

See a number that looks wrong?